Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Fluidigm Corp at Piper Jaffray Healthcare Conference Transcript

Dec 04, 2019 / 06:30PM GMT
Release Date Price: $2.58 (+7.95%)
William Quirk
Piper Jaffray - Tools and Diagnostics Analyst

Good afternoon, everyone. Welcome to the 1: 30 session. I'm Bill Quirk. I'm the Tools and Diagnostics Analyst here at Piper Jaffray and I've got a couple of the key leadership team members from Fluidigm on the stage with me.

To my left, your right, is the President and CEO, Chris Linthwaite, and to Chris' left is the Chief Financial Officer, Vikram Jog. I'm going to hand the mic here over to Chris just to say a few introductory comments and then we'll roll into Q&A and please feel free to join the conversation. So with that, Chris, thanks for joining us.

Chris Linthwaite
Fluidigm Corporation - President and Chief Executive Officer

Thank you very much. Bill, first thanks for the invitation here to present and as always, we appreciate these opportunities to get the word out. I think after what was a difficult third quarter when you actually deconstruct it, we're really only talking about a handful of systems. It doesn't change the outcome, the fact that we missed on the guidance, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot